Britannia Life Sciences Inc (TSE:BLAB)
CNQX:BLAB

Britannia Life Sciences Inc (BLAB) Financial Statements

1 Followers

Britannia Life Sciences Inc Financial Overview

Britannia Life Sciences Inc's market cap is currently ―. The company's EPS TTM is C$0.01; its P/E ratio is 4.76; Britannia Life Sciences Inc is scheduled to report earnings on July 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total RevenueC$ 1.81MC$ 2.07MC$ 1.95MC$ 1.65MC$ 1.65M
Gross ProfitC$ 1.21MC$ 1.48MC$ 1.47MC$ 1.10MC$ 1.23M
EBITC$ 639.82KC$ 1.17MC$ 504.42KC$ 830.83KC$ 397.76K
EBITDAC$ 707.81KC$ 1.24MC$ 558.44KC$ 900.73KC$ 454.70K
Net Income Common StockholdersC$ 535.32KC$ 724.16KC$ -117.72KC$ 636.35KC$ -54.34K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.72MC$ 2.52MC$ 2.43MC$ 2.60MC$ 2.44M
Total AssetsC$ 22.96MC$ 23.87MC$ 24.22MC$ 23.55MC$ 22.97M
Total DebtC$ 7.28MC$ 7.57MC$ 7.95MC$ 8.41MC$ 8.26M
Net DebtC$ 5.56MC$ 5.05MC$ 5.52MC$ 5.81MC$ 5.82M
Total LiabilitiesC$ 11.06MC$ 11.59MC$ 12.15MC$ 12.49MC$ 13.43M
Stockholders EquityC$ 7.91MC$ 7.90MC$ 7.57MC$ 7.02MC$ 5.78M
Cash Flow-
Free Cash FlowC$ 557.99K-C$ 13.00KC$ -435.08KC$ 577.67K
Operating Cash FlowC$ 576.00K-C$ 13.84KC$ -343.50KC$ 660.68K
Investing Cash FlowC$ -952.64K-C$ -2.98MC$ -91.58KC$ -83.01K
Financing Cash FlowC$ -481.48K-C$ 2.98MC$ 539.67KC$ -243.42K
Currency in CAD

Britannia Life Sciences Inc Earnings and Revenue History

Britannia Life Sciences Inc Debt to Assets

Britannia Life Sciences Inc Cash Flow

Britannia Life Sciences Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis